УДК 617.11-004.1-085(042.4)

https://doi.org/10.31288/oftalmolzh201358995

Современные методы лечения синдрома сухого глаза

Г. И. Дрожжина, д. м. н., проф., зав. отделом патологии роговицы

ГУ «Институт глазных болезней и тканевой терапии им. В. П. Филатова НАМИ Украины»

References

1.Brzhesldi VV. Modern possibilities of substitution of the mucin layer of the precorneal tear film. Review. Oftalmo-logia. 2011 8(1): 2-7.

2.Brzheskii VV, Somov EE. Corneal-conjunctival xerosis (diagnosis, clinical features, treatment). St. Petersburg; 2003. 119 p.

3.Yegorov EA, BAsinskii SN. Clinical lectures on ophthal-mology. Moscow: GEOTAR; 2007. 288 p.

4.Kogan BM. The use of pulsed electromagnetic fields for the treatment of dry keratoconjunctivitis. Cand. of Med. Sc. thesis Odessa; 1999. 156 p.

5.Konovalov ME, Milova SE. Dry eye syndrome after refrac-tive operations. Proceedings of Russian scientific practical conference of ophthalmologists «New technologies in the treatment of corneal diseases*. Moscow; 2004. 653- 6.

6.Maichuk YuF, Yani EV. Preparation of new pathogenetic action in dry eye therapy. Kataraktalnaya i refraktsionnaya khirurgia. 2001; 11(2): 2-7.

7.Pasyechnikova NV, Drozhzhina GI, Naumenko GI, Katsan SV, Dragomiretskaya EG. Results of screening epidemio-logic study (DE Screen) of prelevance of dry eye syndrome among women over 40 years in Ukraine. Novosti meditsiny I farmatsii. 2010; 324: 11- 6.
Crossref

8.Somov EE. Etiopathogenic basis of dry eye syndrome and principles of the approach to its treatment. Proceedings of jubilee scientific practical conference, dedicated to 75th an-niversary of the first pediatric ophthalmology department in Russia. 1-16 Oct 2010; StPetersburgh.

9.Brewitt H, Zieherhut M, Trockenes Auge. Heidelberg: Kaden; 2001. 214 p.

10.Davitt W, Bioomerstein M, Ghristensen M. Efficacy in Patients with dry eye after treatment with a new lubricant eye drop formulation. Journal of ocular pharmacology and therapeutics. 2010; 26: 347-53.
Crossref

11.Kunert KS, Tisdale AS, Stern ME. Analysis of topical cy-closporine treatment of in patients with dry eye syndrome. Effect of conjunctival lymphocytes. Arch.Opthapmol. 2000; 118: 1489-96.
Crossref

12.Manucci I, Fregona I, Di Genaro A. Use of a new lacrymal substitute (TS Polysaccharide in contactology. J. Med. contactology and low vision . 2000; 1: 6-9.

13.Marube J, Nemeth J, Hoh K. The triple classification of dry eye for practical and clinical use. Eur. J. Opthalmol. 2005; 15: 660-7.
Crossref

14.Nichols K, Foulks G, Bron A. The International Workshop of Meibomian Gland dysfunction. Invest. Opthalmol. and Vis. Sci. 2011; 52: 1917- 29.
Crossref

15.Paulsen F, Langer G, Hoffman W. Human lacrimal gland mucins. Cell tissue Res. 2004; 316: 167-77.
Crossref

16.Rolando M, Valente C. Establishing the tolerability and performance the tamarind seed polysaccharide (TSP) in the healing dry eye syndrome: results of a clinical study. DVC Ophthalmol. 2007; 7: 5 -14.
Crossref

17.The international Dry Eye Workshop (DEWS). The Ocular Surface 2007; 5: 65 -90
Crossref

18.Wilson SE, Perry HD. Long term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Opthalmology 2007; 114: 76 -9.
Crossref